Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · IEX Real-Time Price · USD
1.250
+0.030 (2.46%)
Jul 22, 2024, 10:08 AM EDT - Market open
Iterum Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Iterum Therapeutics stock has a target of 6.00, which predicts an increase of 380.00% from the current stock price of 1.25.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 21, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ITRM is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +380.00% | Jun 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +380.00% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +380.00% | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +380.00% | Apr 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +380.00% | Apr 1, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.37M
EPS This Year
-1.70
from -2.96
EPS Next Year
-1.03
from -1.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 24.5M | 51.1M | 80.8M | 113.7M |
| Avg | n/a | 12.4M | 26.7M | 45.5M | 70.8M |
| Low | n/a | 911,400 | 3.6M | 12.1M | 29.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 312.6% | 202.9% | 149.7% |
| Avg | - | - | 115.6% | 70.7% | 55.4% |
| Low | - | - | -70.8% | -54.8% | -34.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.66 | -0.77 | -0.39 | -0.60 | 0.23 |
| Avg | -1.70 | -1.03 | -0.69 | -0.58 | 0.22 |
| Low | -1.72 | -1.26 | -0.96 | -0.56 | 0.22 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.